Let’s start up with the current stock price of Black Diamond Therapeutics Inc. (BDTX), which is $29.61 to be very precise. The Stock rose vividly during the last session to $37.76 after opening rate of $35.95 while the lowest price it went was recorded $28.7701 before closing at $34.75.
Recently in News on January 5, 2021, Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference. Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the J.P. Morgan 39th Annual Virtual Healthcare Conference on Tuesday, January 12, 2021 at 7:30 AM ET. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Black Diamond Therapeutics Inc. shares are logging -35.98% during the 52-week period from high price, and 67.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $17.63 and $46.25.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2536783 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Black Diamond Therapeutics Inc. (BDTX) recorded performance in the market was -7.61%, having the revenues showcasing -9.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.06B, as it employees total of 32 workers.
Black Diamond Therapeutics Inc. (BDTX) in the eye of market guru’s
During the last month, 0 analysts gave the Black Diamond Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 31.81, with a change in the price was noted -0.60. In a similar fashion, Black Diamond Therapeutics Inc. posted a movement of -1.99% for the period of last 100 days, recording 276,442 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BDTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Black Diamond Therapeutics Inc. (BDTX): Stocks Technical analysis and Trends
Raw Stochastic average of Black Diamond Therapeutics Inc. in the period of last 50 days is set at 9.34%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 9.34%. In the last 20 days, the company’s Stochastic %K was 55.33% and its Stochastic %D was recorded 66.84%.
If we look into the earlier routines of Black Diamond Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -7.61%. The shares increased approximately by -6.86% in the 7-day charts and went up by -14.59% in the period of the last 30 days. Common stock shares were lifted by -9.70% during last recorded quarter.